FDA: PPIs and Clostridium Difficile

Published Online: Friday, July 20, 2012
Follow Pharmacy_Times:
In this podcast, Steve Jackson, a pharmacist in the FDA’s division of drug information, warns that use of proton pump inhibitors (PPIs) may be associated with an increased risk of Clostridium difficile–associated diarrhea.
 
To listen to the podcast, click here.
Related Articles
More and more proton pump inhibitors (PPIs) are making the jump to OTC status, and this plethora of new options may confuse patients.
Although proton pump inhibitors are widely used, they are not without risks.
Although diarrheal disease Is preventable and treatable, it affects billions of individuals annually.
Which OTC products should you recommend?
Latest Issues
$auto_registration$